(Reuters) – Moderna Inc’s (MRNA.O) Stocks increased by about 11% on Wednesday after a small-scale study showed that its experimental COVID-19 vaccine produced high levels of virus-killing antibodies, raising hopes that the vaccine could be effective in later stages of testing. FILE PHOTO: A sign marks the headquarters of Moderna …
Read More »
LONDON (Reuters) – Emerging evidence that the body’s immune defense against COVID-19 may be short-lived makes it even more difficult for vaccine developers to find vaccines fully capable of protecting people in future waves of infection, Scientists said Tuesday. FILE PHOTO: Professor Gottfried Kremsner injects a coronavirus disease vaccine (COVID-19) …
Read More »
(Reuters) – Doctors in Europe will soon be able to treat COVID-19 patients with Gilead (GILD.O), antiviral drug, remdesivir, after the support of the health regulator set it on the path to becoming the first therapy for the disease on the continent. FILE PHOTO: Pharmaceutical company Gilead Sciences Inc is …
Read More »
LONDON (Reuters) – A test in pigs of AstraZeneca (AZN.L) The experimental vaccine COVID-19 has found that two doses of the injection produce a greater antibody response than a single dose. Research published Tuesday by Britain’s Pirbright Institute found that administering an initial main dose followed by a booster dose …
Read More »